Potential Interactions of Biologically Based Complementary Medicine in Gynecological Oncology.

ABSTRACT:

Objective

The aim of this study was to assess the potential risks of interactions between biologically based complementary and alternative medication (BB-CAM) and conventional drugs during systemic therapy in breast and gynecological cancer patients by analyzing the actual CAM-drug combinations from individual patients' records.

Methods

From September 2014 to December 2014 and from February 2017 to May 2017, all patients (n = 717) undergoing systemic therapy at the Gynecologic Oncology Day Care Unit in the Gynecology and Obstetrics Department of the Technical University of Munich, Germany, were asked to participate in a questionnaire about all their medications. To assess the potential risk of CAM-drug interactions (CDIs), we initially utilized the Lexicomp drug interaction

SUBMITTER: Drozdoff L 

PROVIDER: S-EPMC6501502 | biostudies-literature | 2019 Jan-Dec

REPOSITORIES: biostudies-literature